Efficacy, Tolerability and Safety of Early Introduction of Everolimus, Reduced Calcineurin Inhibitors and Early Steroid Elimination Compared to Standard CNI, Mycophenolate Mofetil and Steroid Regimen in Paediatric Renal Transplant Recipients
Conditions
- Prevention of Acute Rejection in Paediatric Recipients of a Renal Transplant
Interventions
Sponsor
Novartis Pharmaceuticals